Today, KOD’s pipeline includes Phase 3 candidates for DR, RVO, and wet AMD, targeting an $18 billion TAM by 2028. The main catalyst to watch now is their upcoming pivotal data in 2026 that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback